Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 62 (PPIAP62)

Target
PPIAP62
Molecular classification
Other (Pseudogene)
01

Overview

Peptidylprolyl isomerase A pseudogene 62 (PPIAP62) is a processed pseudogene in the human genome, annotated in public databases (HGNC: 53686, NCBI Gene: 101928610, Ensembl: ENSG00000226473). Pseudogenes like PPIAP62 are typically segments of DNA that resemble known genes but contain mutations or deletions that prevent them from producing a functional protein. While some pseudogenes can have regulatory or noncoding RNA functions, there is currently no evidence that PPIAP62 independently acts as a therapeutic target, biomarker, or regulator in human disease, nor that it encodes a receptor, enzyme, transporter, or transcription factor. Additionally, no drugs are known to interact with PPIAP62, and it is not associated with notable safety, toxicity, or biomarker considerations relevant to clinical development. For reference, the parental gene, Peptidylprolyl isomerase A (PPIA), also known as cyclophilin A, is a functional protein implicated in various cellular processes and disease contexts. Some related pseudogenes, such as PPIAP22, have reported RNA-mediated regulatory roles in cancer, but there is currently no evidence for such a role for PPIAP62 specifically.

Other names
Peptidylprolyl isomerase A pseudogene 62PPIAP62
02

Biological functions

Other (non-coding RNA function possible; not a protein-coding gene)
03

Disease associations

No direct, established disease associations; no evidence for a disease mechanism for PPIAP62 specifically

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 62 (PPIAP62).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 62 (PPIAP62).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call